Skip to main content
. 2021 Jun 28;12:683996. doi: 10.3389/fmicb.2021.683996

FIGURE 5.

FIGURE 5

(A) Anticancer activity determined by MTT [-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] assay. Experiments were done by using CFS of 20, 40, 60, 80, 100 μl/ml concentrations from CFS of OUBN1, OUBN3, OUBN4, and OUBN5, respectively. Data shown are triplicate values of mean ± SD of independent experiments. (B) Apoptosis determined for untreated and treated HT-29 cells with OUBN1, OUBN3, OUBN4, OUBN5 isolates by DAPI (4, 6-diamidino-2-phenylindole) staining. Scale 200 μm.